P.0835 Synergistic effects of lysergic acid diethylamide (LSD) and cannabidiol (CBD)

2021 ◽  
Vol 53 ◽  
pp. S610
Author(s):  
A. Inserra ◽  
E. Billard ◽  
E. Grant ◽  
A. Markopoulous ◽  
M. Pilegggi ◽  
...  
2021 ◽  
pp. 1-6
Author(s):  
Matthijs Blankers ◽  
Daan van der Gouwe ◽  
Lavinia Stegemann ◽  
Laura Smit-Rigter

<b><i>Background:</i></b> In this article, we present an evaluation of online psychoactive substance trade via Telegram, a free encrypted social media messenger service. The evaluation took place during the COVID-19 pandemic, which allowed us to monitor the effects of the spring 2020 lockdown in the Netherlands on substance trade via Telegram. <b><i>Objective:</i></b> The objective of this study was to evaluate whether changes in psychoactive substance trade on Telegram markets in the Netherlands can be observed during the COVID-19 pandemic. <b><i>Results:</i></b> Between December 2, 2019, and June 29, 2020, a total of 70,226 posts appeared in two analyzed Telegram groups. A total of 5,643 posts were psychoactive substance related. Based on the analyzed posts, Telegram is mostly a ‘“sellers” market as only a minority of the posts (6.3%) could be identified as a request for a substance. The proportion of posts related to specific substances varied between the periods before, during, and after the lockdown. The proportion of posts on the stimulants ecstasy, cocaine, and amphetamine was lower during the lockdown than before and after. For psychedelics – ketamine, lysergic acid diethylamide (LSD), and 2,5-dimethoxy-4-bromophenethylamine (2C-B) – and other substances, there was a relative increase in the number of posts during the lockdown, which was maintained after the lockdown. <b><i>Conclusions:</i></b> Telegram analysis shows that in the Netherlands, online psychoactive substance trade may have been affected during the COVID-19 pandemic. The direction of this effect was different for different classes of substances.


Science ◽  
1957 ◽  
Vol 126 (3281) ◽  
pp. 1020-1020 ◽  
Author(s):  
H. A. ABRAMSON ◽  
B. SKLAROFSKY ◽  
M. O. BARON ◽  
N. FREMONT-SMITH

1997 ◽  
Vol 4 (5) ◽  
pp. 211 ◽  
Author(s):  
Kari Blaho ◽  
Kevin Merigian ◽  
Stephen Winbery ◽  
Stephen A. Geraci ◽  
Chantay Smartt

1961 ◽  
Vol 107 (446) ◽  
pp. 109-114 ◽  
Author(s):  
Brian M. Davies

Sernyl, 1 aryl-cyclo-hexylamine, is a synthetic drug first used by the anaesthetists because, when given intravenously, it produces analgesia. However, the occurrence of psychological disturbances post-operatively led to the investigation of this drug by psychiatrists. It was found that Sernyl produces many interesting psychological disturbances, some of which resemble the primary symptoms of schizophrenia (Davies and Beech, 1960). In a previous paper (Davies, 1960) Sernyl was given intravenously to five patients with long-standing psychoneurotic illnesses. It proved to be an effective abreactive agent and produced some interesting results in three of the patients who had obsessional symptoms. Sernyl, in the doses used, is not an hallucinogen, though it produces other effects similar to lysergic acid diethylamide, which has been used extensively as a therapeutic agent, particularly in obsessional states (Sandison et al., 1954). The preliminary report suggested that Sernyl might have some practical advantages over LSD—in particular, it produced a less severe disturbance and its effects were over more quickly. Further investigations were clearly indicated and this present paper reports on the use of oral Sernyl in five patients with obsessional illnesses.


1984 ◽  
Vol 97 (1-2) ◽  
pp. 87-93 ◽  
Author(s):  
David P. Geaney ◽  
Michael Schächter ◽  
J.Martin Elliot ◽  
David G. Grahame-Smith

Sign in / Sign up

Export Citation Format

Share Document